MSB0011359C (M7824) in Subjects With Metastatic or Locally Advanced Solid Tumors (Q63813324)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MSB0011359C (M7824) in Subjects With Metastatic or Locally Advanced Solid Tumors |
clinical trial |
Statements
A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of MSB0011359C (M7824) in Subjects With Metastatic or Locally Advanced Solid Tumors With Expansion to Selected Indications in Asia (English)
0 references
11 March 2016
0 references
31 December 2020
0 references
114
0 references
20 year
0 references